|
|
|
Volumn 24, Issue SUPPL. 2, 2003, Pages
|
|
Pharmacogenomics: State of the research and perspectives in clinical application
a
a
a
a
|
|
Author keywords
ADRs; Migraine; Pharmacogenomics
|
|
Indexed keywords
DAPSONE;
DRUG CARRIER;
DRUG METABOLIZING ENZYME;
DRUG RECEPTOR;
FLUOXETINE;
HYDRALAZINE;
ISONIAZID;
METOPROLOL;
NAPROXEN;
PROCAINAMIDE;
SULFADIMIDINE;
AGE;
ALCOHOL CONSUMPTION;
ARTICLE;
CLINICAL PRACTICE;
CLINICAL RESEARCH;
DNA POLYMORPHISM;
DRUG DEVELOPMENT;
DRUG EFFICACY;
DRUG INTERACTION;
DRUG RESPONSE;
DRUG TOXICITY;
GENETIC DISORDER;
GENETIC SUSCEPTIBILITY;
GENETIC VARIABILITY;
HEALTH CARE COST;
HEREDITY;
HUMAN;
KIDNEY FUNCTION;
LIFESTYLE;
LIVER FUNCTION;
LIVER TOXICITY;
MIGRAINE;
MORBIDITY;
MORTALITY;
PERIPHERAL NEUROPATHY;
PHARMACOGENOMICS;
RISK ASSESSMENT;
RISK FACTOR;
SIDE EFFECT;
SMOKING;
TREATMENT FAILURE;
ACETYLATION;
DRUG TOXICITY;
HUMANS;
MIGRAINE DISORDERS;
OXIDATION-REDUCTION;
PHARMACOGENETICS;
POLYMORPHISM, GENETIC;
RISK FACTORS;
|
|
EID: 0038314302
PISSN: 15901874
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (11)
|
|
References (10)
|
